Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Youdim

Showing results (171-180 of 349) with videos related to

Pageof 35
Sort By:
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?M B Youdim, D Ben-Shachar, P Riederer
Advances in Neurology|January 1, 1993
Recent advances in pharmacological therapy of Parkinson's diseaseP Riederer, K W Lange, M B Youdim
British Journal of Pharmacology|February 1, 1975
Variation in activity of monoamine metabolizing enzymes in rat liver during pregnancyS Parvez, S H Parvez, M B Youdim
British Journal of Pharmacology|February 13, 2001
Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase BM B Youdim, A Gross, J P Finberg
European Neurology|January 1, 1991
Iron in brain function and dysfunction with emphasis on Parkinson's diseaseM B Youdim, D Ben-Shachar, P Riederer
Journal of Neurochemistry|October 1, 1996
Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivoI Lamensdorf, M B Youdim, J P Finberg
Psychopharmacology Bulletin|July 1, 1974
Proceedings: Multiple forms of MAO: some in vivo correlationsM Sandler, M B Youdim, C M Pare
Biochemical Pharmacology|July 15, 1972
Multiple forms of monoamine oxidase. Comparison of in vitro and in vivo inhibition patternsG G Collins, M B Youdim, M Sandler
Neurochemistry International|May 25, 2010
Serotonin neurochemistry revisited: A new look at some old axiomsD M Kuhn, W A Wolf, M B Youdim
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Neurochemical perspectives to the function of monoamine oxidaseP Riederer, C Konradi, G Hebenstreit, et al.
Pageof 35

Showing results (171-180 of 349) with videos related to

Sort By:
Pageof 35
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?M B Youdim, D Ben-Shachar, P Riederer
Advances in Neurology|January 1, 1993
Recent advances in pharmacological therapy of Parkinson's diseaseP Riederer, K W Lange, M B Youdim
British Journal of Pharmacology|February 1, 1975
Variation in activity of monoamine metabolizing enzymes in rat liver during pregnancyS Parvez, S H Parvez, M B Youdim
British Journal of Pharmacology|February 13, 2001
Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase BM B Youdim, A Gross, J P Finberg
European Neurology|January 1, 1991
Iron in brain function and dysfunction with emphasis on Parkinson's diseaseM B Youdim, D Ben-Shachar, P Riederer
Journal of Neurochemistry|October 1, 1996
Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivoI Lamensdorf, M B Youdim, J P Finberg
Psychopharmacology Bulletin|July 1, 1974
Proceedings: Multiple forms of MAO: some in vivo correlationsM Sandler, M B Youdim, C M Pare
Biochemical Pharmacology|July 15, 1972
Multiple forms of monoamine oxidase. Comparison of in vitro and in vivo inhibition patternsG G Collins, M B Youdim, M Sandler
Neurochemistry International|May 25, 2010
Serotonin neurochemistry revisited: A new look at some old axiomsD M Kuhn, W A Wolf, M B Youdim
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Neurochemical perspectives to the function of monoamine oxidaseP Riederer, C Konradi, G Hebenstreit, et al.
Pageof 35